Have a personal or library account? Click to login
Can Dexrazoxane and Carvedilol prevent Doxorubicin-induced nephrotoxicity? Cover

Can Dexrazoxane and Carvedilol prevent Doxorubicin-induced nephrotoxicity?

Current Issues in Pharmacy and Medical Sciences
Volume 37 (2024): Issue 4 (December 2024)
By: Jaroslaw Szponar,  Agnieszka Gorska,  Marta Ostrowska-Lesko,  Bartosz Wielgomas and  Slawomir Mandziuk  
Open Access
|Nov 2024

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/cipms-2024-0038 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Journal RSS Feed
Language: English
Page range: 232 - 239
Submitted on: Jun 14, 2024
|
Accepted on: Oct 11, 2024
|
Published on: Nov 28, 2024
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
post-anthracycline nephrotoxicity,
nephroprotection,
dexrazoxane,
carvedilol,
doxorubicin
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Pharmacology, toxicology,
Pharmacy,
Pharmacy, other

© 2024 Jaroslaw Szponar, Agnieszka Gorska, Marta Ostrowska-Lesko, Bartosz Wielgomas, Slawomir Mandziuk, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 37 (2024): Issue 4 (December 2024)Next article